CVS Health Corporation ($CVS) Stock Forecast: Down 7.3% Today

What is CVS Health Corporation?

CVS Health Corporation (NYSE: CVS) is a healthcare company specializing in pharmacy and healthcare services. The company is focused on enhancing its financial standing and broadening its service offerings.

Why is CVS Health Corporation going down?

CVS stock is down 7.3% on Oct 30, 2025 13:36

• Despite surpassing third-quarter earnings projections and increasing annual guidance, CVS stock faced a decline in value.
• It is possible that the market responded negatively as some investors were anticipating even more robust results despite the positive earnings and revenue outcomes.
• The decline in CVS stock could also be linked to some investors seizing gains after expecting a more significant market response.
• The CEO's initiatives to boost profits and enhance stock performance may not have fully convinced investors about the company's potential for long-term growth, which contributed to the stock's decline.

CVS Price Chart

CVS Technical Analysis

CVS News

CVS Health Stock Hits 52 Week High - CVS Health ( NYSE:CVS )

CVS Health Corp ( NYSE:CVS ) on Wednesday reported better-than-expected third-quarter earnings and raised its annual guidance. The company reported sales of $102.87 billion, beating the consensus of $98.84 billion. Total revenues increased 7.8% year-over-year, driven by revenue growth across ...

https://www.benzinga.com/markets/earnings/25/10/48496368/cvs-health-delivers-confident-outlook-after-q3-performance-stock-hits-52-week-high

CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up

CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.

https://www.zacks.com/stock/news/2779932/cvs-stock-falls-despite-q3-earnings-revenue-beat-25-eps-view-up

CVS Health ( CVS ) Surpasses Q3 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of +17.65% and +4.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2779809/cvs-health-cvs-surpasses-q3-earnings-and-revenue-estimates

CVS beats estimates, hikes guidance as insurance business improves

The third-quarter results mark David Joyner's first full year as CEO of CVS, which had struggled to drive higher profits and improve its stock performance.

https://www.cnbc.com/2025/10/29/cvs-health-cvs-earnings-q3-2025.html

Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?

CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.

https://www.zacks.com/stock/news/2778694/is-cvs-healths-pharmacy-consumer-wellness-poised-for-a-stronger-q3

Trending Today

Bitcoin ($BTC) Crypto Forecast: Down 5.4% Today

Plug Power Inc. ($PLUG) Stock Forecast: Down 8.6% Today

Micron Technology Inc. ($MU) Stock Forecast: Up 6.8% Today

Beyond Meat Inc. ($BYND) Stock Forecast: Up 7.9% Today

Lucid Motors Inc. ($LCID) Stock Forecast: Down 5.7% Today

Alibaba Group Holding Limited ($BABA) Stock Forecast: Down 2.2% Today

CleanSpark Inc ($CLSK) Stock Forecast: Down 6.8% Today

Soybeans ($SOY) Commodity Forecast: Down 2.3% Today

Corn ($CORN) Commodity Forecast: Down 1.3% Today

DoorDash Inc. ($DASH) Stock Forecast: Up 5.1% Today

CVS Health Corporation Price History

17.03.2025 - CVS Stock was down 7.2%

• CVS stock saw a decline of -0.55% and -1.87% in recent trading sessions.
• A comparison between CVS Health and UnitedHealth may have influenced investors' decisions, leading to some selling pressure on CVS stock.
• Uncertainty around healthcare policies and regulations may have also affected the bearish trend in CVS stock.
• Monitoring upcoming developments in the healthcare sector is crucial for investors to gauge the performance of CVS Health stock.

24.06.2025 - CVS Stock was down 5.1%

• Despite the anticipation of surpassing earnings expectations and encouraging indications of a possible revival, CVS stock faced a significant downtrend.
• The decrease in Q2 earnings predictions and worries regarding the company's performance might have overshadowed the positive developments, contributing to the market's bearish movement.
• Investors could have responded unfavorably to the uncertainties surrounding CVS's future performance, notwithstanding the company's efforts to enhance its Health Care Benefits division and potential signs of a turnaround.
• Despite the stock being technically oversold and receiving favorable evaluations from analysts, these factors may not have been sufficient to counterbalance the existing concerns, resulting in CVS's bearish trajectory today.

30.09.2025 - CVS Stock was down 7.3%

• Despite surpassing third-quarter earnings projections and increasing annual guidance, CVS stock faced a decline in value.
• It is possible that the market responded negatively as some investors were anticipating even more robust results despite the positive earnings and revenue outcomes.
• The decline in CVS stock could also be linked to some investors seizing gains after expecting a more significant market response.
• The CEO's initiatives to boost profits and enhance stock performance may not have fully convinced investors about the company's potential for long-term growth, which contributed to the stock's decline.

31.06.2025 - CVS Stock was up 6.4%

• CVS Health (CVS) exceeded both earnings and revenue estimates for the second quarter, showcasing strong financial performance and potentially indicating positive growth prospects.
• Analysts revised their expectations for CVS Health ahead of its earnings release, with a slight decrease in projected quarterly earnings per share compared to the previous year.
• Despite concerns about rising medical costs, CVS' Health Care Delivery unit demonstrated robust growth, driven by key partnerships with Signify and Oak Street, which likely contributed to investor optimism.
• The stock's recent slide amidst a rising market might be attributed to short-term fluctuations or profit-taking, rather than reflecting any fundamental issues with the company's performance.

01.04.2025 - CVS Stock was up 6.9%

• CVS Health outperformed expectations in the first quarter, prompting an increase in its full-year EPS guidance, which in turn boosted its stock value.
• A partnership with Novo Nordisk to improve access to Wegovy, a weight loss treatment, for CVS drug plan members played a role in boosting investor confidence.
• The company's strong financial results, highlighted by a sharp increase in adjusted EPS and operating income, bolstered the upward momentum of the stock.
• The market's positive reaction demonstrates faith in CVS's strategies and financial performance, leading to upward movement in the stock price even amidst market volatility.

01.04.2025 - CVS Stock was up 9.7%

• CVS Health (CVS) saw a notable upward movement in trading today.
• The company's Q1 earnings and revenues surpassed market expectations by a substantial margin, which likely instilled confidence among investors.
• The decision to prioritize Novo Nordisk's weight loss treatment Wegovy on its formulary may have also contributed to the positive market sentiment, hinting at potential growth avenues and improved healthcare offerings.
• Analysts' positive projections for CVS Health's earnings growth, along with the anticipation of a robust earnings performance, may have additionally bolstered the bullish momentum, attracting increased investor interest in the stock.

02.04.2025 - CVS Stock was down 4.4%

• CVS Health reported better-than-expected first-quarter results and raised its FY25 EPS guidance, leading to a sharp rise in its stock price.
• The partnership with Wegovy maker Novo Nordisk and the significant improvement in adjusted EPS and operating income contributed to the positive market sentiment towards CVS.
• The earnings and revenue beats in Q1 2025, along with the raised EPS view, further fueled investor confidence in CVS Health, driving the stock price higher.
• Despite the positive news and strong financial performance, the market might have reacted bearishly due to profit-taking or broader market factors impacting CVS's stock price negatively.

02.08.2025 - CVS Stock was up 1.3%

• The positive momentum in its Health Care Benefit segment, driven by government plans despite facing utilization pressures, contributed to the bullish movement in CVS stock today.
• Strong investor confidence in CVS's future prospects and fundamental strength is reflected in the stock hitting a 52-week high.
• Investors may currently view CVS as a better value and stronger investment option compared to other healthcare stocks like HealthEquity and Elevance.
• CVS's focus on Aetna margin recovery, digital investments, and cost savings is resonating well with investors, contributing to the bullish market movement.

13.04.2025 - CVS Stock was down 5.2%

• The decline in CVS stock value could be linked to a recent executive order that aims to align U.S. drug prices with those of other countries, potentially impacting the company's financial performance.
• Although there were positive sentiments in options trading, the general market outlook has shifted negatively, resulting in the drop in CVS stock.
• Glenview Capital's remarks about CVS Health's progress in its long-term transformation might have been overshadowed by broader market anxieties, contributing to the stock's downturn.
• Investor perception of CVS Health compared to other industry peers may have also played a role in the stock price decrease.

13.04.2025 - CVS Stock was down 7.0%

• The bearish movement in CVS stock today could be attributed to investors potentially favoring Danaher (DHR) over CVS as a better value option in the Medical Services sector.
• Glenview Capital's statement on CVS Health may have failed to reassure investors about the company's long-term turnaround plans, leading to a lack of confidence in CVS stock.
• The overall sentiment in the market towards healthcare stocks might have also contributed to the bearish movement in CVS, as investors may be cautious about regulatory impacts and competitive pressures in the sector.

08.03.2025 - CVS Stock was up 8.7%

• CVS Health's recent appointment of a new CFO, along with strong Q4 sales that surpassed expectations, has instilled confidence among investors, resulting in a rise in the stock price.
• The company's consistent cash generation and impressive track record of earnings have positioned it well amidst broader market uncertainties, such as concerns about increasing tariffs.
• While there have been some bearish movements in the options market, the overall sentiment towards CVS Health remains positive, with a significant portion of traders displaying bullish inclinations.
• The temporary halt by the FTC on a lawsuit involving CVS Health, Cigna, and UnitedHealth's PBMs may have offered some relief to investors, contributing to the stock's upward trend.

29.09.2025 - CVS Stock was up 0.3%

• CVS outperformed Q3 earnings and revenue projections by a considerable margin.
• CEO David Joyner's successful first year at CVS led to improved profits and stock performance, bolstering investor faith.
• Recent advancements within CVS's Pharmacy & Consumer Wellness division, such as technological enhancements and strategic acquisitions, supported the stock's upward trajectory.
• Despite a slight dip in the stock price during the last trading session, the optimistic news and outlook surrounding CVS have attracted investor attention and confidence in the company's future growth prospects.